FdaApplication
ANDA 209825
Identifiers
- fda_app_no: ANDA209825
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2017-08-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE;INJECTION |
1 product